DeepMed Research

University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Patient Automated Text Hovering for IBD

Not Applicable

Completed

Conditions: Inflammatory Bowel Diseases
Ulcerative Colitis
Crohn Disease

Interventions: Behavioral: Text-based Clinical Hovering
Behavioral: Control

First Posted Date: 2020-05-14

Last Posted Date: 2023-02-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 150

Registration Number: NCT04388865

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

COVIDNOCHE Trial (HFNO Versus CPAP Helmet) in COVID-19 Pneumonia

Not Applicable

Withdrawn

Conditions: COVID
Severe Acute Respiratory Syndrome Coronavirus 2
Hypoxemic Respiratory Failure
Pneumonia, Viral

Interventions: Device: High Flow Nasal Oxygen (HFNO)
Device: Helmet Continuous Positive Airway Pressure (CPAP)

First Posted Date: 2020-05-11

Last Posted Date: 2022-04-05

Lead Sponsor: University of Pennsylvania

Registration Number: NCT04381923

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19

Completed

Conditions: Coronavirus
Respiratory Failure

Interventions: Other: Observation only

First Posted Date: 2020-05-07

Last Posted Date: 2023-09-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 125

Registration Number: NCT04379544

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Effect of PARP Inhibitors on Glomerular Filtration Rate

Terminated

Conditions: Breast Cancer
Solid Tumor
Ovarian Cancer

Interventions: Other: Kidney Function Test

First Posted Date: 2020-04-29

Last Posted Date: 2022-01-26

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 2

Registration Number: NCT04367467

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

INO 5401 Vaccination in BRCA1/2 Mutation Carriers

Phase 1

Active, not recruiting

Conditions: BRCA1/2 Mutation

Interventions: Drug: INO-5401
Device: Cellectra 2000
Drug: INO-9012

First Posted Date: 2020-04-29

Last Posted Date: 2025-04-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 44

Registration Number: NCT04367675

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Multicomponent Behavioral Sleep Intervention for Insomnia in Older Adults With Mild Cognitive Impairment

Not Applicable

Completed

Conditions: Mild Cognitive Impairment
Insomnia

Interventions: Behavioral: Active Control
Behavioral: Multicomponent Behavioral Sleep Intervention for Insomnia

First Posted Date: 2020-04-28

Last Posted Date: 2024-05-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 27

Registration Number: NCT04364191

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Effect of U=U Messaging on HIV in South Africa

Not Applicable

Completed

Conditions: HIV/AIDS

Interventions: Behavioral: U=U messaging and invitation to free HIV testing at mobile clinic
Behavioral: Standard invitation to free HIV testing at mobile clinic

First Posted Date: 2020-04-27

Last Posted Date: 2024-02-26

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1048

Registration Number: NCT04364165

Locations: 🇿🇦
Desmond Tutu HIV Foundation, Cape Town, Western Cape, South Africa

Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019

Not Applicable

Completed

Conditions: COVID-19

Interventions: Other: Discontinuation of ARB/ACEI
Other: Continuation of ARB/ACEI

First Posted Date: 2020-04-08

Last Posted Date: 2021-04-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 152

Registration Number: NCT04338009

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

Phase 4

Recruiting

Conditions: Genetics Disease
Type2 Diabetes
Heart Failure

Interventions: Drug: Sitagliptin 100mg
Drug: Placebo Oral Tablet

First Posted Date: 2020-03-26

Last Posted Date: 2024-07-29

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 20

Registration Number: NCT04323189

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Mechanisms of Upper Airway Obstruction

Not Applicable

Completed

Conditions: Obstructive Sleep Apnea

Interventions: Device: Lingual Muscle Stimulation
Other: Mandibular advancement
Other: Postural maneuvers
Other: Digital Morphometrics
Other: Tongue Force Exercise
Other: Magnetic resonance imaging (MRI)
Other: Polysomnography (PSG) - Split Night

First Posted Date: 2020-03-26

Last Posted Date: 2025-04-23

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 133

Registration Number: NCT04322097

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy